<DOC>
	<DOCNO>NCT02055547</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , pharmacokinetics pharmacodynamics MK-8521 . The primary hypothesis MK-8521 sufficiently safe well-tolerated healthy , lean obese male .</brief_summary>
	<brief_title>A Single Multiple-Dose Study MK-8521 Healthy Obese Males ( MK-8521-002 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Males either 18 45 45 70 year age depend component study Body Mass Index either 1825 3040 kg/m^2 depend component study Is good health Is nonsmoker and/or use nicotine least 3 month Is mentally legally incapacitate , significant emotional problem history psychiatric disorder past 5 year Has history follow abnormality disease : endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary , major neurological . History cancer History significant multiple severe allergy anaphylactic reaction significant intolerability drug food Positive hepatitis B surface antigen , hepatitis C antibodies human immunodeficiency virus ( HIV ) Had major surgery , donate lose 1 unit ( 500 mL ) blood participate another study within prior 4 week Has irritable bowel disease recurrent nausea , vomit , diarrhea abdominal pain History acute chronic pancreatitis Uses 2 week prior trial , anticipate use trial , medication , drug herbal remedy St. John 's Wort Consumes great 3 glass alcohol per day Consumes great 6 serving caffeinated beverage per day Regularly use illicit drug history drug ( include alcohol ) abuse within prior 3 month Has know hypersensitivity glucagon glucagon like peptide 1 ( GLP1 ) receptor agonist Is unwilling/unable consume standardize meal and/or carbohydrate restrict diet Has history hypersensitivity pharmacologic insulin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>